3003 90 — Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. antibiotics containing hormones or steroids used as hormones, but not containing antibiotics, alkaloids or derivatives thereof, hormones, antibiotics, antimalarial active principles or goods of heading 3002, 3005 or 3006)

3003 Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale: 3003 10 – containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives 3003 20 – other, containing antibiotics – other, containing hormones or other products of heading 2937: 3003 31 – – containing insulin 3003 39 – – other – other, containing alkaloids or derivatives thereof: 3003 41 – – containing ephedrine or its salts 3003 42 – – containing pseudoephedrine (INN) or its salts 3003 43 – – containing norephedrine or its salts 3003 49 – – other 3003 60 – other, containing antimalarial active principles described in Subheading Note 2 to this Chapter 3003 90 – other

This heading covers medicinal products used for internal or external use or for the prevention of human or animal diseases. Such means are obtained by mixing two or more components. However, packaged in dosage form or in retail packages, they are classified in heading 3004. This heading includes: (1) Mixed medicaments, such as preparations listed in official pharmacopoeias, proprietary preparations, etc., including preparations manufactured in the form of throat and mouth rinses, eye drops, ointments, liniments, injectable solutions, anti-inflammatory and other preparations, not included in heading 3002, 3005 or 3006. However, it is not to be understood that preparations registered in official pharmacopoeias, proprietary preparations, etc. are always classified in heading 3003. For example, acne preparations intended primarily for skin cleansing and not containing sufficiently high concentrations of active ingredients to be considered as having primary therapeutic or prophylactic effect against acne are to be classified in heading 3304. (2) Preparations containing one active substance in a mixture with a filler, sweetener, agglomerating substance, carrier, etc. (3) Drugs intended for nutrition, administered exclusively intravenously, for example, by intravenous infusion through a syringe or dropper. (4) Colloidal solutions and suspensions (for example, colloidal selenium) for medical purposes, except for colloidal sulfur or precious metals in the colloidal state.

Colloidal sulphur is classified in heading 3004 when packaged as dosage forms or in retail packages for therapeutic or prophylactic use and in heading 2802 in all other cases. Precious metals in the colloidal state are classified in heading 2843, whether they are used in sludge or not for medical purposes. Mixtures of precious metals in a colloidal state or mixtures of one or more precious metals in a colloidal state with other substances used for therapeutic or prophylactic purposes are, however, classified in this heading. (5) Medicinal complex plant extracts, including extracts obtained by processing plant mixtures. (6) Medicinal mixtures of plants or plant parts of heading 1211. (7) Therapeutic salts obtained by evaporation of natural m ineral waters, and similar products obtained artificially. (8) Concentrated water of salt sources (e.g. Kreutsnach water) used in therapy; mixtures of salts prepared for therapeutic baths (sulphur, iodine, etc. baths), without the addition or with the addition of aromatic substances. (9) Therapeutic salts (for example, a mixture of sodium bicarbonate, tartaric acid, magnesium sulfate and sugar) and similar mixed gas-emitting salts used for medical purposes. (10) Camphor oil, phenolic oil, etc. (11) Anti-asthmatic products such as anti-asthmatic paper and powders. (12) "Long-acting drugs", such as preparations in which the drug component is fixed on a polymeric ion exchange material. (13) Anesthetics used in medicine, veterinary medicine or surgery. The provisions of this heading do not apply to foodstuffs or beverages such as dietary, diabetic or nutritionally fortified foodstuffs, tonic beverages or minerals in odes (natural or artificial) which fall under the relevant headings. This is usually the case with dietary supplements containing only nutrients. The main nutrients in foods are proteins, carbon levodes and fats. Vitamins and mineral salts also play a role in nutrition. Similarly, foodstuffs and beverages containing medicinal substances are not included in this heading if these substances are added for the sole purpose of improving the dietary balance, increasing the energy content or nutritional value of the product or improving its taste and aromatic qualities, provided that the product retains its properties as a food or beverage. In addition, products consisting of a mixture of plants or parts of plants, or consisting of plants and parts of plants mixed with other substances, used for the preparation of herbal infusions or herbal “teas” (for example, herbal infusions or herbal “teas” having laxatives, cleansing, diuretics or wind-burning properties), and which are said to alleviate malaise or favorably affect general health and well-being, are also excluded from this heading (heading 2106). In addition, this heading does not include food additives containing vitamins or mineral salts which are prepared for the purpose of promoting health and improving well-being, but have no instructions for their use for the prevention or treatment of diseases or ailments. Such products, usually manufactured in liquid form but which may also be supplied in powders or tablets, are generally classified in heading 2106 or Chapter 22.

However, this heading covers preparations in which a food product or drink merely serves as a carrier, filler or sweetener for medicinal substances (for example, to improve digestion). In addition to foodstuffs and beverages, this heading does not include: (a) goods of heading 3002, 3005 or 3006; (b) aqueous distillates or aqueous solutions of essential oils and goods of headings 3303 to 3307, even if they have therapeutic or prophylactic properties (Chapter 33); (c) soaps containing medicinal products (heading 3401); (d) insecticides, disinfectants, etc. of heading 3808.

Notes

Machine translation. The original is the Russian text of the EAEU tariff, and customs goes by it; this translation is for understanding only and has no legal force.

1. This group does not include:

(a) food or beverages (such as dietary, diabetic or nutritionally fortified foods, food additives, tonic beverages and mineral waters), other than nutrient preparations for intravenous administration (Section IV);

(b) products such as tablets, chewing gum or patches (transdermal systems) containing nicotine and intended to contribute to the cessation of tobacco consumption (heading 2404);

(c) specially calcified or finely ground plasters for use in dentistry (heading 2520);

(d) aqueous distillates or aqueous solutions of essential oils intended for medical use (heading 3301);

(e) preparations of headings 3303 to 3307, even if they have therapeutic or prophylactic properties;

(f) soap or other products of heading 3401 containing medicinal additives;

(g) g gypsum-based products for use in dentistry (heading 3407);

(h) blood albumin not prepared for therapeutic or prophylactic use (heading 3502); or

(ij) diagnostic reagents of heading 3822.

2. For the purposes of heading 3002, the term “immunological products” applies to peptides and proteins (other than those of heading 2937) which are directly involved in the regulation of immunological processes such as monoclonal antibodies (MABs), antibody fragments, antibody conjugates and antibody fragment conjugates, interleukins, interferons (IFNs), chemokines and certain tumor necrosis factors (TNFs), growth factors (GFs), hematopoietines and colony-stimulating factors (CSFs).

3. In headings 3003 and 3004 and note 4(d) to this chapter it is understood:

(a) unmixed products:

(1) unmixed products dissolved in water;

(2) all goods of Chapter 28 or 29; and

(3) simple plant extracts of heading 1302, only standardized or dissolved in any solvent;

(b) under mixed products:

(1) colloidal solutions and suspensions (except colloidal sulfur);

(2) plant extracts obtained by treatment of mixtures of plant raw materials; and

(3) salts and concentrates obtained by evaporation of natural mineral waters.

4. Heading 3006 covers only the following products, which are to be classified in this and no other heading of the Nomenclature:

(a) sterile surgical ketgut, similar sterile suture materials (including sterile absorbable surgical or dental threads) and sterile adhesive tissues for surgical wound closure;

(b) sterile kelp and sterile tampons of kelp;

(c) sterile resorbable surgical or dental hemostatic agents (hemostatics); sterile surgical or dental adhesive barriers, resorbable or non-absorbable;

(d) contrast preparations for X-ray examinations and diagnostic reagents intended for administration to patients, which are unmixed substances in dosage forms or substances consisting of two or more components mixed for such use;

(e) placebos and sets of impersonal clinical preparations for the conduct of approved clinical trials by simple blind (or double blind) method, packaged in dosage forms, even if they may contain active (active) medicinal substances;

(f) dental cements and other materials for filling teeth; cements for reconstructing bone;

(g) sanitary bags and first aid kits;

(h) chemical contraceptives based on hormones, other compounds of heading 2937 or spermicides;

(ij) preparations in the form of a gel intended for use in medicine or veterinary medicine as a lubricant for body parts in surgical operations or physical investigations or as a binding agent between the body and medical instruments;

(k) unsuitable pharmaceuticals, i.e. pharmaceutical products, which are not suitable for use for their original purpose, for example because they have expired; and

(l) devices identified as devices for stomic use, i.e. colostomy, ileostomy and urostomy bags cut in shape and their sticky plates or front parts.

Subheading notes

English text as published in Annex I to Regulation (EU) 2021/1832 (Combined Nomenclature). The EAEU tariff and the EU nomenclature copy these notes from the same convention. For a Russian declaration the binding version is the Russian one: Annex to Decision No 80 of the EEC Council of 14 September 2021.

1. For the purposes of subheadings 3002 13 and 3002 14, the following are to be treated:

(a) as unmixed products, pure products, whether or not containing impurities;

(b) as products which have been mixed:

(1) the products mentioned in (a) above dissolved in water or in other solvents;

(2) the products mentioned in (a) and (b) (1) above with an added stabiliser necessary for their preservation or transport; and

(3) The products mentioned in (a), (b) (1) and (b) (2) above with any other additive.

2. Subheadings 3003 60 and 3004 60 cover medicaments containing artemisinin (INN) for oral ingestion combined with other pharmaceutical active ingredients, or containing any of the following active principles, whether or not combined with other pharmaceutical active ingredients : amodiaquine (INN); artelinic acid or its salts; artenimol (INN); artemotil (INN); artemether (INN); artesunate (INN); chloroquine (INN); dihydroartemisinin (INN); lumefantrine (INN); mefloquine (INN); piperaquine (INN); pyrimethamine (INN) or sulfadoxine (INN).